Patents by Inventor Steven Paul Linke

Steven Paul Linke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230136619
    Abstract: The present technology generally relates to methods and compositions relevant to the prediction that a subject with and/or after treatment for DCIS will experience a subsequent ipsilateral breast event that is a DCIS recurrence, an invasive breast cancer, both a DCIS recurrence and invasive cancer, or neither. The technology can assist one with how to treat such subjects.
    Type: Application
    Filed: February 24, 2022
    Publication date: May 4, 2023
    Inventors: Troy M. Bremer, Steven Paul Linke
  • Patent number: 11543411
    Abstract: The present technology generally relates to methods and compositions relevant to the prediction that a subject with and/or after treatment for DCIS will experience a subsequent ipsilateral breast event that is a DCIS recurrence, an invasive breast cancer, both a DCIS recurrence and invasive cancer, or neither. The technology can assist one with how to treat such subjects.
    Type: Grant
    Filed: December 4, 2015
    Date of Patent: January 3, 2023
    Assignee: Prelude Corporation
    Inventors: Troy M. Bremer, Steven Paul Linke
  • Publication number: 20170350895
    Abstract: The present technology generally relates to methods and compositions relevant to the prediction that a subject with and/or after treatment for DCIS will experience a subsequent ipsilateral breast event that is a DCIS recurrence, an invasive breast cancer, both a DCIS recurrence and invasive cancer, or neither. The technology can assist one with how to treat such subjects.
    Type: Application
    Filed: December 4, 2015
    Publication date: December 7, 2017
    Inventors: Troy M. Bremer, Steven Paul Linke